Correlation Between Acrivon Therapeutics, and Bio Path
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Bio Path Holdings, you can compare the effects of market volatilities on Acrivon Therapeutics, and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Bio Path.
Diversification Opportunities for Acrivon Therapeutics, and Bio Path
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Acrivon and Bio is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Bio Path go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Bio Path
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.76 times more return on investment than Bio Path. However, Acrivon Therapeutics, Common is 1.31 times less risky than Bio Path. It trades about 0.01 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.05 per unit of risk. If you would invest 1,250 in Acrivon Therapeutics, Common on August 29, 2024 and sell it today you would lose (515.00) from holding Acrivon Therapeutics, Common or give up 41.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Bio Path Holdings
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Bio Path Holdings |
Acrivon Therapeutics, and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Bio Path
The main advantage of trading using opposite Acrivon Therapeutics, and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals | Acrivon Therapeutics, vs. Seres Therapeutics |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |